In-Bore MRI-Guided Prostate Biopsy Now Being Used for Early Prostate Cancer Detection

In-Bore MRI-Guided Prostate Biopsy Now Being Used for Early Prostate Cancer Detection
Although there is no prevention for prostate cancer, early detection and regular screening are the best approaches to reduce the number annual deaths. To this end, researchers at Desert Medical Imaging led by Dr. John F. Feller, Medical Director and owner of the company, recently conducted their 500th in-bore, MRI-guided prostate biopsy. A diagnostic MRI creates a detailed cross-sectional image of the prostate gland without an invasive procedure. DMI’s Board Certified Radiologists can then examine the images using Computer Aided Detection to identify areas in the gland that look suspicious; these areas may be further evaluated through a targeted MR-guided biopsy. According to the Centers for Disease Control and Prevention (CDC), prostate cancer is the most common cancer among American men, and it is also one of the leading causes of cancer death among men of all races and Hispanic populations. In 2011, the CDC estimations showed that 209,292 men in the United States were diagnosed with prostate cancer and that 27,970 men died from the disease. "The technology targets prostate lesions in order to better grade and stage prostate cancer and reduce pain, bleeding and risk of infection," said Feller in a recent press release. "MRI-guided biopsies have proven to be more accurate than random, transrectal ultrasound (TRUS) biopsy, which has a documented false-negative rate of 30-35% for the detection of c
Subscribe or to access all post and page content.